Smiths Medical Receives FDA Clearance
Selected Abstract
Smiths Medical Receives FDA Clearance for Expansion of Power Injectable Port Line Including a New Arm Port.
ST. PAUL, Minn. -- Smiths Medical, part of the global technology business Smiths Group, announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the P.A.S. PORT([R]) T2 POWER P.A.C. and PORT-A-CATH([R]) II POWER P.A.C. Dual-lumen Implantable Access ... January 15, 2008; Business Wire
Read the full article with a free-trial membership at HighBeam Research
Related Articles 1.
Smiths Medical Receives FDA Clearance for Next Generation CADD(R)-Solis Ambulatory Infusion System.
2.
Smiths Medical Receives FDA Clearance for Power Injectable Ports and Safety Needles.
3.
Smiths Medical Receives FDA Clearance for Expansion of Power Injectable Port Line Including a New Arm Port.
|
